The global oxygen therapy equipment market is experiencing robust growth, driven by the rising prevalence of respiratory disorders, increased utilization in critical care settings, and rapid ...

HONOLULU -- Although single maintenance and reliever therapy (SMART, or MART) marks a new chapter in asthma treatment, its advocates acknowledged practical limitations during a debate at the CHEST ...

Children, as well as their parents, may one day be able to breathe a little easier: The respiratory therapy company Vapotherm said a pilot study of its high-flow treatment showed it could outperform ...

In children with moderate-to-severe asthma, telemedicine intervention with therapy in schools improves asthma outcomes, ...

CHICAGO -- A fixed-dose inhaler combining an inhaled corticosteroid, long-acting muscarinic antagonist, and long-acting beta agonist (ICS/LAMA/LABA) improved lung function and reduced exacerbations in ...

A new guideline from the American College of Allergy, Asthma, and Immunology provides evidence-based recommendations for stepping down asthma medications for patients who have achieved sustained ...

Patients with obesity and asthma who used GLP-1 receptor agonists had significantly fewer exacerbations and prednisone use ...

Researchers have found that the inclusion of a third drug to commonly used dual-drug inhalers can reduce asthma exacerbations and improve control over the disease in children, adolescents, and adults ...

Kenya has received a major boost to its health system with the delivery of new Global Fund-financed oxygen equipment to strengthen medical care and Universal Health Coverage.

The Ministry of Health has flagged off over 10,000 oxygen equipment units under the Global Fund C19RM oxygen infrastructure ...

Chinese scientists have developed a groundbreaking cell therapy that could provide long-term relief for asthma patients with just a single shot. This new treatment, which has shown promising results ...

Please provide your email address to receive an email when new articles are posted on . 42.6% of patients filled a SABA prescription 30 days before an exacerbation, and 61.4% did so within 30 days ...